Forget Password?
  1. Indices
  2. Commodities
  3. Currencies
Straits Times 3,114.16 -11.98 -0.38%
Hang Seng 26,719.58 -128.91 -0.48%
Dow Jones 26,833.43 -192.45 -0.71%
Shanghai Composite 2,938.14 -39.19 -1.32%
iX Biopharma Secures Indonesia Patent For Waferix™ Technology
Daily Bulletin | 01 December 2015
Related stocks:

iX Biopharma has secured a patent in Indonesia for its WaferiX™ drug delivery technology, the sixth country to-date. The group was recently granted its Japanese patent in September 2015, while patents have already been granted in Australia, Malaysia, New Zealand and Singapore.

Pending applications are currently under examination in major markets including the US, Europe, China, India, Canada, South Korea, South Africa, Hong Kong, and Thailand. The patent covers a fast-dissolving oral dosage form for the release of a biologically active material in the oral cavity, and provide strategic coverage for iX Biopharma’s WaferiX™ technology in Indonesia. The patent will expire on 26 October 2030.

iX Biopharma  0.210 -0.010 -4.55%   
Business: Late-stage specialty pharmaceutical firm. [FY18 Turnover] Chemical analysis (95.6%), nutraceutical (2.4%), specialty pharmaceutical (2%).

Insight: May-19, 9M19 revenue jumped 206.2% due to project ... Read More

Join The Conversation
The Shares Investment editorial team welcomes constructive feedback on our coverage and content. We would also be delighted to answer any questions on the above article. Leave us a comment below, and we'll get back to you shortly!

All Rights Reserved. Pioneers & Leaders (Publishers) Pte Ltd. Best viewed with Mozilla Firefox 3.5 and above.